Author

Sadanori Miyoshi

Observed name: S Miyoshi

Institution: Astellas Pharma (Japan)

Observed institutions: Astellas Pharma (Japan), Hirosaki University, The University of Tokyo

ORCID: 0000-0001-9456-6774

Observed ORCID: 0000-0001-9456-6774

OpenAlex ID: A5035659662

DOK7 gene therapy enhances motor activity and life span in ALS model mice

2017 · Sadanori Miyoshi, Tohru Tezuka, et al. · EMBO Molecular Medicine · 74

Postnatal knockdown of dok‐7 gene expression in mice causes structural defects in neuromuscular synapses and myasthenic pathology

2016 · Takahiro Eguchi, Tohru Tezuka, et al. · Genes to Cells · 28

The carboxyl-terminal region of Dok-7 plays a key, but not essential, role in activation of muscle-specific receptor kinase MuSK and neuromuscular synapse formation

2017 · Ryo Ueta, Tohru Tezuka, et al. · The Journal of Biochemistry · 11

The Hsp90 inhibitor 17‐AAG represses calcium‐induced cytokeratin 1 and 10 expression in HaCaT keratinocytes

2012 · Sadanori Miyoshi, Shota Yamazaki, et al. · FEBS Open Bio · 8

[A patient with motor neuron syndrome clinically similar to amyotrophic lateral sclerosis, presenting spontaneous recovery].

2000 · K Miyoshi, Y Ohyagi, et al. · PubMed · 5

[Molecular mechanisms underlying the formation and maintenance of neuromuscular junctions and a possible therapeutic approach.]

2017 · Takahiro Eguchi, Tohru Tezuka, et al. · PubMed · 1

Novel compounds induce AChR clustering and improve motor function in myasthenia gravis animal models

2026 · Asako Saito, Ryuichi Sekioka, et al. · Biochemical and Biophysical Research Communications

Works count: 7

Citation count: 127

H-index: 5

I10-index: 3